Researchers
-
Anna Planas Ballvé
Clinical neuropsychiatry and neuropsychology
-
Asunción Ávila
Clinical neuropsychiatry and neuropsychology
Phd -
Dolores Lozano
Clinical neuropsychiatry and neuropsychology
-
Ester Moral Torres
Clinical neuropsychiatry and neuropsychology
-
Irati Zubizarreta
Clinical neuropsychiatry and neuropsychology
Phd -
Joan Bello López
Clinical neuropsychiatry and neuropsychology
Phd -
José Vicente Hervas-garcía
Clinical neuropsychiatry and neuropsychology
Phd -
Juan Bernardo Gómez
Clinical neuropsychiatry and neuropsychology
-
Juan José Mengual
Clinical neuropsychiatry and neuropsychology
-
Laura Gubieras Lillo
Clinical neuropsychiatry and neuropsychology
-
Mª Isabel Gómez Ruiz
Clinical neuropsychiatry and neuropsychology
Phd -
Marta Balagué
Clinical neuropsychiatry and neuropsychology
-
Mercè Leixà
Clinical neuropsychiatry and neuropsychology
-
Mireia Grau
Clinical neuropsychiatry and neuropsychology
-
Monica Prat
Clinical neuropsychiatry and neuropsychology
-
Montse Vacas Moreira
Clinical neuropsychiatry and neuropsychology
-
Nuria Caballol
Clinical neuropsychiatry and neuropsychology
-
Pablo Millet Balance
Clinical neuropsychiatry and neuropsychology
-
Sonia Maria Garcia
Clinical neuropsychiatry and neuropsychology
-
Xavier Cardona
Clinical neuropsychiatry and neuropsychology
Contact the group
Form
Projects
-
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Systematic observational method for narcolepsy and influenza immunization assessment. A focusing on AS03 adjuvant,
-
DISTRICT ATTORNEY:
Centers for Disease Control and Prevention (CDC) Atlanta USA
-
TYPE E:
EPA
-
- Year 2014
- L'Hospitalet General Hospital
Study for the psychometric validation of the CORE-OM in Catalan,
-
DISTRICT ATTORNEY:
Barcelona University
-
TYPE E:
PINE TREE
-
- Year 2014
- L'Hospitalet General Hospital
Multicenter study to evaluate the prevalence of Niemann-Pick C disease in patients with movement disorders.
-
DISTRICT ATTORNEY:
Movement Disorders Group (GTEM) of the Spanish Society of Neurology (SEN)
-
TYPE E:
PINE TREE
-
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Retrospective observational study to describe the tolerability of Gilenya (Fingolimod) at the start of treatment in routine clinical practice. I study MS Law,
-
DISTRICT ATTORNEY:
Novartis Pharmaceutical SA
-
TYPE E:
EPA
-
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Satisfaction with injectable immunomodulator treatment in patients with Isolated Demyelinating Syndrome (SDA) or Relapsing Relapsing Multiple Sclerosis (RRMS),
-
DISTRICT ATTORNEY:
Sanofi-Aventis SA
-
TYPE E:
EPA
-
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Retrospective observational study. Study of the cost of the outbreak of multiple sclerosis in Catalonia,
-
DISTRICT ATTORNEY:
Novartis Pharmaceutical SA
-
TYPE E:
EPA
-
- Year 2014
- L'Hospitalet General Hospital
Early detection of Alzheimer's disease in balanced and unbalanced Catalan-Spanish bilingual patients. Validation of verbal tools,
-
DISTRICT ATTORNEY:
Dr. Mª Isabel Gómez
-
TYPE E:
PINE TREE
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Exploratory study to look for biomarkers in peripheral blood to monitor treatment with Gilenya ® (Fingolimod) in patients with relapsing remitting multiple sclerosis,
-
DISTRICT ATTORNEY:
Germans Trias i Pujol Health Sciences Research Institute Foundation
-
TYPE E:
EPA
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Exploratory study to validate the usefulness of the ultrasonographic study of the diameter of the optic nerve as a measurement parameter of axonal degeneration compared to OCT in patients with relapsing remitting multiple sclerosis,
-
DISTRICT ATTORNEY:
Consorci Sanitari Integral
-
TYPE E:
PI
-
Clinical neuropsychiatry and neuropsychology
Researcher
- Year 2013
- Sant Joan Despí Moisès Broggi Hospital
Observational, retrospective and transversal study to evaluate suboptimal compliance in patients with relapsing-remitting multiple sclerosis who present with an outbreak after a minimum of 6 months of treatment with IFN beta-1a,
-
DISTRICT ATTORNEY:
Merck SL
-
TYPE E:
EPA
- Parkinson's disease in our area
- Psychiatric pathology in neurological diseases
- Bilingualism in dementia, stroke and movement disorders
- Multiple Sclerosis: treatment and quality of life
- Cognitive and fluid biomarkers in neurodegenerative disorders
